Medical Studies > CASE STUDY > Case Solutions/ Notes for Genentech capacity Planning By Daniel C. Snow, Steven C. Wheelwright, Alis (All)

Case Solutions/ Notes for Genentech capacity Planning By Daniel C. Snow, Steven C. Wheelwright, Alison Berkley

Document Content and Description Below

While facilitating a complex clinical approval process over the next two to three years for a family of new cancer drugs, Genentech must develop a long-term capacity plan for a major class of new canc ... er products. Adding to the complexity and uncertainty is the fact that the lead time for planning, building, and certifying a new $600 million plus production-scale facility is five years. In addition, ensuring that the best process technology is incorporated into such a new plant makes the task facing David Ebersman, the senior vice-president of products operations, and his management team a daunting one. Frames the issues Ebersman and his team face and outlines the approach to date. [Show More]

Last updated: 2 years ago

Preview 1 out of 32 pages

Buy Now

Instant download

We Accept: